Phenikaa Group and South Korea’s GC Group Sign Joint Venture Agreement for Healthcare Innovations

Phenikaa Group has partnered with GC Group (South Korea), opening up opportunities to access new diagnostics technologies that are the most advanced and modern, particularly in the early diagnosis of genetic disorders and cancer in Vietnam. At the same time, this collaboration with South Korea’s leading conglomerate in testing, diagnostics, screening, and healthcare will enhance the quality and completion of Phenikaa Group’s Healthcare Ecosystem with an orientation toward digital technology integration.

At Phenikaa University, the Signing Ceremony of the Joint Venture Agreement in the Healthcare Sector between Phenikaa Group and Green Cross (GC) marked a significant milestone in international cooperation to establish a Comprehensive Premium Healthcare System. This system will particularly focus on state-of-the-art testing and advanced and all-encompassing diagnostic services for medical examinations and treatment in Vietnam.

Attending the signing ceremony, on the side of Phenikaa Group, there was the participation of Assoc. Prof. Dr Ho Xuan Nang – Chairman of Phenikaa Group and representatives of the Phenikaa Health Care Ecosystem leadership. On the side of GC Group, present were Mr. Huh Yong Jun – CEO of GC Group; Mr. Lee Sang Gon – President of Green Cross Laboratories, and representatives from related units.

The focal point of this joint venture agreement is establishing a joint company, with the initial phase focusing on healthcare examination, testing, screening, and diagnosis using the latest world-class technologies. Amidst the rising concerns over cancer in Vietnam, with over 180,000 new cases annually and a mortality rate ranked 50th out of 185 countries (according to GLOBOCAN, the International Agency for Research on Cancer), the GC-Phenikaa Joint Venture was established with the mission to provide world-class healthcare services utilizing the most advanced technologies for screening, diagnosis, and effective treatment solutions for healthy individuals, those at risk, and cancer patients. In collaboration with Phenikaa University Hospital, the Joint Venture will establish a center offering comprehensive, high-quality, and convenient international-standard screening, diagnosis, and treatment services not only in Vietnam but also across Southeast Asia. This center will be located within the Phenikaa University Hospital project (scale: 800-bed capacity, total area of 26,096 square meters) in Nam Tu Liem district, Hanoi, offering two main services, which is: (i) Advanced Diagnosis, Screening, and Testing Services: These services are provided by Green Cross Laboratories, the premier diagnostic testing institution in South Korea renowned for its internationally leading diagnostic capabilities. Green Cross Laboratories operates a diagnostic system that processes approximately 95 million samples annually and has 17 testing centers worldwide, and (ii) Premium Health Check-up Services: Offered by Green Cross i-Med – a leading company in health check-ups, currently delivering comprehensive health care services to senior executives and employees of 1,500 major companies and individual clients in South Korea and internationally.

Assoc. Prof. Dr Ho Xuan Nang – Chairman of Phenikaa Group gave a souvenir to Mr. Huh Yong Jun – CEO of GC Group

Comprehensive Health Diagnostic Center specializing in Genetics and Cancer, aims to become a leader in advanced diagnostic testing and premium health check-ups in Vietnam, featuring: state-of-the-art medical equipment, cutting-edge digital solutions from GC Group – one of the leading corporations in diagnostics, screening, and health care in South Korea, with nearly 60 years of experience; top medical experts with a team of leading doctors and healthcare specialists from South Korea; integrated services provided by the synergy between the Center and the Phenikaa University Hospital project, as well as the broader Phenikaa Health Care Ecosystem, ensuring a seamless process of examination, testing, diagnosis, and advanced treatment solutions, thereby establishing a high-quality health care service chain.

“To enhance the Phenikaa Group’s Healthcare Ecosystem, investments are directed towards an Internationally Accredited Medical System of Pharmaceutical Research and Development, Production and Testing, and The Establishment of Health Science Training Programs at Phenikaa University. Collaborations with reputable and renowned global healthcare entities for technology transfer, service quality enhancement, and experience exchange are among the strategic steps that Phenikaa Group is progressively undertaking.

We aspire to create internationally standard diagnostic, testing, and healthcare facilities in Vietnam, reducing wait times for test results while improving diagnostic accuracy and timeliness, particularly for genetic disorders, cancer, rare diseases, etc. This will enable us to provide advanced solutions to support the best possible treatment for patients. Well-functioning facilities will create conditions for both Vietnamese and foreigners residing in Vietnam to receive high-quality healthcare locally, eliminating the need to travel abroad for medical care. Moreover, it will attract foreigners to Vietnam for tourism and medical treatment, offering international quality care at significantly lower costs than overseas.” – Representative of Phenikaa Group shares.

Additionally, thanks to this joint venture collaboration, Phenikaa University – a training and research institution oriented towards experience and innovation – will have its teaching and learning activities supported and promoted through internships, practical training, research, application, and transfer of scientific research results. This will contribute to completing Phenikaa Group’s Healthcare Ecosystem under the “3 Centers” model from training, and research to production and service provision. Phenikaa-X, a technology company under the Phenikaa Group, will develop the joint venture’s IT system to ensure seamless digital connectivity across all operations. This will enhance the digital hospital model, optimize medical data collection and analysis, and pave the way for the gradual implementation of artificial intelligence in screening, diagnosis, and treatment.

Phenikaa believes that this collaboration will create breakthroughs in the Healthcare sector, bringing significant value and enhancing the quality of Community Healthcare services. This will contribute to new advancements in the nation’s Medical field while fulfilling community responsibilities based on Phenikaa Group’s conscientious business culture.

Related

Source: Vietnam Insider